HempFusion Wellness Inc.
The Future of Health & Wellness
A Message from Hemp’s CEO and Co-founder Jason Mitchel, N.D.
HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs including tinctures, proprietary FDA Drug Listed Over The Counter (OTC) Topicals, Doctor/Practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex™ and are available in-store or by visiting HempFusion online at www.hempfusion.com or www.probulin.com.
HempFusion Wellness Inc. is headquartered in Denver, Colorado and is a leader in the health and wellness CBD industry, providing innovative and diversified proprietary formulations utilizing the power of whole-food hemp nutrition. The Company is not a hemp cultivator, instead focusing its efforts on product development and distribution. Invested heavily in regulatory compliance, HempFusion aims to consistently meet and even exceed the high standards required by retailers and consumers – putting safety, quality and consistency first. In support of these efforts, the company is U.S. Hemp Authority Certified and is a current board member of the U.S. Hemp Roundtable, a coalition of leading companies committed to advancing safe hemp and CBD products. HempFusion reported 1,750 shareholders and $18.3 million in cash as of June 30, 2020 – the second-largest cash position in its sector – with no debt. Looking ahead, the company is currently preparing to launch an IPO directly onto the Toronto Stock Exchange (“TSX”) senior board, where it has already reserved ticker symbol ‘CBD.U’.
HempFusion Corporate Update Leading into IPO
Brandon Colwell sits down with HempFusion’s Chief Corporate Officer Danny Brody to get the answer to some of the pressing questions on investors minds leading into their IPO financing round and soon to be go public date.
“Cash is King” HempFusion (TSX:CBD.U) begins trading
We’re very excited to see HempFusion go public today on the TSX as CBD.U, with over $30M USD in cash on hand! This is one to keep an eye on.
Near Term Milestones for HempFusion post IPO
Now that HF is trading, it’s important to know the milestones to be looking out for as we push forward in 2021. In this short 2 minute clip Danny Brody lays out what you should be expecting as an investor!
Health & Wellness Company Up 100% Since IPO Jan 6th: 2021 Growth Plan with CEO Jason Mitchell
We sat down with Dr. Jason Mitchell, CEO of one of the newest health & wellness companies to hit Toronto’s big board TSX that has seen its share rise over 100% since its debut on Jan 6, 2020.
USDA Organic Certification Sets This Health & Wellness Company Apart From Their Competition
We had Dr. Jason Mitchell explain how having such a strong focus on product quality helped his he-mp infused health & wellness company receive their USDA organic certification and why it was such an important milestone to ensure that they provide the best products they possibly can to consumers.
There Will Soon Be CB|) 2.0 Hitting Consumers & This Company is Positioned to Be An Industry Leader
Dr. Jason Mitchell explains how with this new wave of CB|) 2.0, it will be important to focus on regulatory and legal matters around this he-mp infused products. That’s why his company has poured millions of dollars into ensuring they abide by these rules & regulations and consumers can trust their products to be of the highest quality.
Capital Markets Update with CCO Danny Brody of HempFusion
With their stock reaching All Time Highs last week, we sat down with Danny Brody to discuss what’s been going on from a capital markets front with HempFusion and what catalysts he’s excited about in the near term for investors.
The diverse product portfolio showcased by HempFusion includes 46 products that are currently on shelves. The company’s leading offerings include HempFusion-owned Biome Labs, HF Labs and Probulin. Due to the time and resources allocated to increasing the compliance of these proprietary products, HempFusion may have a competitive advantage and create additional retail opportunities that are not available for other CBD companies.
HempFusion’s focus and investment into regulatory compliance has opened doors to major food and drug mass or big box retailers that are not available to other CBD companies. This strategic approach includes five distinct channels:
Big Box / Food
and Drug Mass
HempFusion’s branded line of products is based on the company’s proprietary Whole Food Panoramic Full-Spectrum Hemp Complex. Each product is condition- specific, targeting needs such as sleep, energy and stress.
All of HempFusion’s products are made from DNA-verified, European Union registered, non-GMO, organic INDUSTRIAL HEMP
The company’s offerings span multiple product categories, including:
Tinctures and Capsules
These offerings make up the most popular product category in the $4 billion U.S. CBD market. 10mg Plant Based CBD Vegan Gummies.
HempFusion is one of the few CBD companies marketing FDA Drug Listed Topicals. The FDA compliance standards ensure that these products meet the standards set by larger national retailers.
HempFusion has OTC products that are condition-specifically targeted.
OTC Pain Products
The global pain relief market for topicals is projected to reach $13.3 billion by 2025, with a CAGR from 2018 to 2025 of 7.4%.
OTC Eczema Products
The global dermatitis market is projected to reach $13.6 billion by 2026.
OTC Acne and
The global market for beauty and anti-aging products is currently estimated at $1.08 trillion.
OTC First Aid and Wound Healing Products
In 2019, the 10 top selling first aid ointments in the United States generated over $650 million in sales.
and Digestive Enzymes
Probulin Probiotics is 100% wholly owned subsidiary of HempFusion Wellness Inc. and is currently one of the fastest growing probiotics brands in the United States according to Spins syndicated data.
The Probulin product line addresses a wide range of consumer needs, including daily care, total care, women’s health and children’s products.
The probiotics market represents a growing opportunity, as it is estimated to reach $7 billion globally by 2022. Because of the diverse offerings of the Probulin line, it serves as HempFusion’s gateway to retailers who may not currently carry CBD products. This ‘Trojan Horse Strategy’ is intended to allow the company to establish, develop and build relationships among these retailers. By achieving approved vendor status, the company may be able to facilitate faster onboarding times, enabling accelerated access to its CBD products in the future
HF Labs and Biome Research – Doctor and Practitioner Product Lines
The HF Labs and Biome Research product lines are directed toward doctors and practitioners and cater to hospitals, compounding pharmacies and free-standing dispensaries. With an estimated target market of 28,000+ integrative medical doctors and 70,000+ licensed chiropractors in the United States, these offerings create a unique market opportunity as HempFusion continues to broaden its footprint in the CBD industry.
Research on CBD and Human Safety
HempFusion is one of 12 CBD companies selected to participate in ValidCare’s groundbreaking study regarding CBD and human safety, which is expected to be complete by the end of October 2020. The study is designed to address previous questions from the FDA regarding CBD products.
As part of this study, HempFusion and the other selected companies will be conducting human trials to determine if the daily use of full-spectrum hemp-derived CBD or CBD isolate impacts the human liver.
- The Company’s diverse product portfolio includes 46 products on the market from tinctures to proprietary FDA Drug Listed Over The Counter (“OTC”) Topicals to Doctor/Practitioner Lines; including condition-specific products for Sleep, Stress, and Energy
- Products currently sold in 4,000+ retail locations across 50 states including Amazon, Whole Foods, Sprouts, Vitamin Shoppe, Fresh Thyme Market, and a major unannounced national FDM retailer
- One of only a handful of companies participating in a unique industry-first Human Safety Study, (Liver Toxicology, 2020) with ValidCare in response to FDA questions in the public realm
- HempFusion’s uncompromising approach to regulatory compliance has positioned the Company remarkably well to enter major retail channels unavailable to a vast majority of CBD companies including Big Box (Food/Drug/Mass, i.e. Costco), Doctor/Practitioner, and Convenience
- FDA Drug Listed OTC Topicals allow access to the largest channel by dollar value; Big Box which, if entering only the top 5, could contribute up to $108.5M in revenue
- OTC Topical line includes creams and balms that specifically target acne, anti-aging, sports pain relief, eczema relief, wound care, and more
- Unique trojan horse strategy with the Company’s wholly owned Probulin Probiotics, the fastest growing probiotics company in the US, whose products act as a gateway to increased international distribution and approved vendor status with major domestic retailers
- International Expansion – HempFusion and Probulin products selling across Europe (Ireland & UK), and Probulin has purchase orders and/or is selling in the Middle East, South Korea, China, Mexico, and India
- Second largest cash position in the sector, US$18,315,734 cash (June 30th) and no debt
- Over 30 products under development including OTC Drug Listed Ingestibles and additional topicals; with new USDA certified products on shelves now
- Newly developed plant-based CBD gummies are designed specifically for launch into the Convenience Channel, which provides direct access to impulse purchases and significant new sales & distribution opportunities
- Significant revenue opportunity across 5 channels; Natural, e-Commerce, Big Box, Convenience and Doctor/Practitioner
- HempFusion is a board member of the US Hemp Roundtable, a coalition of leading companies committed to safe hemp and CBD products, and Ola Lessard, HempFusion’s CMO, is the President of the US Hemp Roundtable GRAS Affirmation (October/November 2020 publishing) & NOAEL Safety Review completed for all topicals and newly approved USDA Organic product rollout in Q2
- Extensive leadership, finance, legal, CPG, governance, and M&A experience on the executive team including a bolstered board of directors with significant public market experience ahead of our IPO
- Incredibly uniquely positioned within the fast-moving CBD industry with sales expected to reach US$16.8 billion by 2025
HempFusion Wellness Inc. Completes USD$17,000,000 Initial Public Offering and Commences Trading on the Toronto Stock Exchange
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (“HempFusion” or the “Company”) is pleased to announce that it has completed its initial public offering of 7,000,000 common shares of the Company (the “Offered Shares”) at a price of USD$1.00 per Offered Share (the “Offering Price”) for gross proceeds of USD$7,000,000 (the “Share Offering”) and 10,000,000 units of the Company (the “Units”) at the Offering Price per Unit for gross proceeds of USD$10,000,000 (the “Unit Offering” and collectively with Share Offering, the “Offering”).
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has received USDA Organic Certification for its HempFusion CBD tinctures ranging in potency from 150mg (5mg per serving) to 1500mg (50mg per serving) of CBD per bottle, making HempFusion one of the first publicly traded CBD companies to achieve such distinction.
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce its entrance into the European market through an exclusive distribution agreement with a European distributor with an extensive retail store network. With full acknowledgement of the Food Safety Authority of Ireland (FSAI), the expansion includes fully European Union compliant labeling, packaging and distribution for select HempFusion CBD & Probulin Probiotics products.
HempFusion’s Wholly Owned Subsidiary Probulin Probiotics Launches Amazon Store and Expands Brick and Mortar Product Selection
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its wholly owned subsidiary, Probulin Probiotics, LLC (“Probulin”), has increased its product selection in certain brick and mortar locations and expanded its distribution on Amazon through a unique eCommerce store within the Amazon platform.
HempFusion Announces Large-Scale Distribution Agreement with Fullscript.com to Launch Doctor Practitioner Sales Channel
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has entered into a large-scale distribution agreement with Fullscript.com (“Fullscript”), a leading eCommerce platform that allows health professionals to dispense professional-grade natural health products.
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (FWB:8OO) (“HempFusion” or the “Company”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ETFs”), AdvisorShares Pure US Cannabis ETF (NYSE:MSOS) and AdvisorShares Pure Cannabis ETF (NYSE:YOLO). AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“AUM”).
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the“Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its wholly-owned subsidiary, Probulin Probiotics, LLC (“Probulin”), has launched its Total Care Immune probiotic product nationally with a number of major retailers including Sprouts Farmers Markets, Abby’s and Fresh Thyme Markets.
HempFusion Wellness Inc. Becomes Exclusive CBD and Probiotics Sponsor of Loenbro Motorsports for 2021 Racing Season
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (“HempFusion” or the“Company”), is pleased to announce an exclusive partnership with Loenbro Motorsports, one of the world’s leading race teams, making HempFusion CBD, a leading brand utilizing the power of whole-food hemp nutrition, and Probulin, one of the fastest growing probiotic brands in the U.S. according to SPINs reported data, the exclusive sponsors in their respective categories for the 2021 racing season.
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (OTC Pink:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce it has secured its OTC Markets trading symbol, “CBDHF,” allowing a broader U.S. investor audience the ability to trade shares in the Company. “As a US-based CBD company, this important step allows a broader range of US investors to access the Company,” commented Jason Mitchell N.D., HempFusion’s co-founder and CEO.
HempFusion’s Chief Marketing Officer, Ms. Ola Lessard, Elected President of The U.S. Hemp Roundtable for Second Consecutive Term
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce Ms. Ola Lessard, HempFusion’s Chief Marketing Officer, has been elected to her second consecutive term as President of the U.S. Hemp Roundtable (the “Roundtable”), one of the most influential non-profit organizations advocating for national hemp legislation in the United States.
HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that Mount Sinai Medical Hospital, New York City, has selected HempFusion CBD to be used as the exclusive brand and the sole supplier in a six-month clinical trial. The clinical trial, comprised of two studies, is being conducted by Dr. David Harnick, a board-certified cardiologist and electrophysiologist and Assistant Professor in Medicine and Cardiology at Mount Sinai, and is one of the first of its kind in the area of CBD’s effect on targeted cardiology markers.
DENVER–(BUSINESS WIRE)–HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system. DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States.
Jason Mitchell, N.D.,
is the co-founder, Director and CEO of HempFusion. He has over 20 years of experience in the natural products industry and is a naturopathic doctor certified by the ANMCB. Mitchell received his doctorate from the Trinity College of Natural Health and is a member of the American Naturopathic Medical Association and the CNHP. He is an expert in supplemental formations and was responsible for successfully creating and launching over 300 industry-leading products during his 15-year tenure at Country Life Vitamins.
is the Chief of Brand Strategy & Partnerships and a Director for HempFusion. He isa serial entrepreneur with experience in early-stage cannabis and hemp companies. In 2010, he acquired his first cannabis CO2 extraction company in the United States.
DeQueiroz has facilitated the licensing process for many companies in the United States, as well as one of Jamaica’s premier cannabis companies, Epican Medicinals Ltd.
is HempFusion’s Chief Revenue Officer. He has over 25 years of experience in all areas of sales and marketing, with a proven track record of consistently driving growth across all major channels. Visser was previously the Senior Vice President of Sales at Navajo Inc., a multi-national manufacturer/distributor of brands like Pennzoil Automotive Supplies, Piranha Eyewear and Navajo Inc., the largest distributor of trial- and travel-sized health and beauty products in the United States. Visser grew annual sales from $60 million to $128 million in less than three years while at Navajo Inc.
Bruce Valentine Jr.
is the Chief Financial Officer of HempFusion. He has a proven track record working with high-growth companies and was named CFO of the Year in 2013 by the Northern Colorado Business Report. Valentine is the former CFO of Otter Products and has over 15 years of financial management experience.
is the Chief Marketing Officer of HempFusion and is also the President of the U.S. Hemp Roundtable. She has experience in marketing creative and effective brand strategies. She is a former Vice President of Marketing at Barlean’s, an award-winning supplements provider based in Washington.
is the Director of the Doctor/Practitioner Channel. She has over 25 years as an active, licensed practitioner. Angelini travels the country as a lecturer and product manager. She is responsible for opening doors to some of the largest doctor/practitioner networks in the United States.
is the Chief Corporate Officer of HempFusion. He is the co-founder and former Vice President of The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF). Brody has been instrumental in listing multiple world-class cannabis
companies, including TGOD, Emblem Corp. and Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF). Before joining the cannabis industry, he spent seven years working at two leading Canadian brokerage firms..
WE’D LIKE TO KEEP YOU UP-TO-DATE WITH HEMPFUSION BUSINESS NEWS
Thank you for
Someone will reach out to you shortly
Return into homepage
© 2020 HempFusion®. All Rights Reserved.